Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)
European Journal of Cancer2018Vol. 103, pp. 249–258
Citations Over TimeTop 11% of 2018 papers
Christopher M. Nutting, James P. Morden, Matthew Beasley, Shreerang Bhide, Audrey Cook, Emma De Winton, Marie A. Emson, Mererid Evans, Lydia Fresco, Simon Gollins, Dorothy M. Gujral, Kevin J. Harrington, Mano Joseph, Catherine Lemon, Linda Luxon, Qurrat van den Blink, R. Mendes, Aisha Miah, Kate Newbold, Robin Prestwich, Martin Robinson, Paul Sanghera, Joanna Simpson, Muthiah Sivaramalingam, Narayanan Srihari, Mark Sydenham, E. Wells, Stephanie Witts, Emma Hall
Abstract
CS-IMRT reduced the radiation dose below the accepted tolerance of the cochlea, but this did not lead to a reduction in the proportion of patients with clinically relevant hearing loss.
Related Papers
- → Randomized Controlled Drug Trials on Very Elderly Subjects: Descriptive and Methodological Analysis of Trials Published Between 1990 and 2002 and Comparison With Trials on Adults(2005)36 cited
- → Practice and Educational Effects of a Simulated Randomized Controlled Trial for Acupuncture School Teachers(2010)
- → Randomized Controlled Trials for Creating Scientific Evidence of the Efficacy and Safety of Complementary and Alternative Medicine(2004)
- A compatision between one visit RCT and several visit RCT for cracked teeth.(2007)
- Basical Clinical Observation of Cracked Tooth with One visit RCT(2003)